Literature DB >> 8343516

Purification of human thioredoxin reductase: properties and characterization by absorption and circular dichroism spectroscopy.

J E Oblong1, P Y Gasdaska, K Sherrill, G Powis.   

Abstract

The flavoenzyme thioredoxin reductase (TR) and its natural substrate thioredoxin comprise a redox system generally found in all organisms. In order to better understand the biochemistry of this redox system, TR was purified (> 4000-fold) from human placenta as a dimer of 60-kDa subunits. The molecular size of native TR was determined to be 160 kDa by gel filtration chromatography whereas migration on a sucrose gradient gave a molecular mass of 130 kDa. The pI of TR was determined to be 4.85. The temperature optima for DTNB and insulin reduction by TR were 52 and 40 degrees C, respectively. Preincubation of TR at 60 degrees C for up to 1 h showed no decrease in the enzymatic rates when assayed at 28 degrees C, while temperatures above 65 degrees C resulted in an irreversible loss of activity. Circular dichroism (CD) spectra of TR indicated that the secondary structural changes at 60 degrees C were only partly reversible at 28 degrees C. CD studies showed the flavoenzyme had a TM of 63 degrees C and above 45 degrees C began to exhibit changes in the secondary structure. Equilibrium denaturation of TR by temperature and guanidine hydrochloride suggested that FAD was not displaced during inactivation of TR and that the tertiary structure was primarily disrupted prior to denaturation of the secondary structure. The results of this study show that purified human TR is a relatively thermostable flavoenzyme whose tightly bound FAD group is not displaced by elevated temperatures up to 60 degrees C or by relatively low concentrations of guanidine hydrochloride.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8343516     DOI: 10.1021/bi00079a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

Review 1.  Thioredoxin and glutathione system of malaria parasite Plasmodium falciparum.

Authors:  S Müller; T W Gilberger; Z Krnajski; K Lüersen; S Meierjohann; R D Walter
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

Review 2.  Thioredoxin reductase.

Authors:  D Mustacich; G Powis
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

3.  Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene.

Authors:  V N Gladyshev; K T Jeang; T C Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli.

Authors:  L D Arscott; S Gromer; R H Schirmer; K Becker; C H Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Heparin-binding properties of selenium-containing thioredoxin reductase from HeLa cells and human lung adenocarcinoma cells.

Authors:  S Y Liu; T C Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 6.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.

Authors:  Samuel Lee; Soo Min Kim; Richard T Lee
Journal:  Antioxid Redox Signal       Date:  2012-06-26       Impact factor: 8.401

7.  Functional expression of rat thioredoxin reductase: selenocysteine insertion sequence element is essential for the active enzyme.

Authors:  N Fujiwara; T Fujii; J Fujii; N Taniguchi
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

Review 8.  [Expression of selenoproteins in monocytes and macrophages--implications for the immune system].

Authors:  R Ebert-Dümig; J Seufert; D Schneider; J Köhrle; N Schütze; F Jakob
Journal:  Med Klin (Munich)       Date:  1999-10-15

Review 9.  A systems biology perspective on Nrf2-mediated antioxidant response.

Authors:  Qiang Zhang; Jingbo Pi; Courtney G Woods; Melvin E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-28       Impact factor: 4.219

10.  Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase.

Authors:  Garth Powis; Peter Wipf; Stephen M Lynch; Anne Birmingham; D Lynn Kirkpatrick
Journal:  Mol Cancer Ther       Date:  2006-03       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.